SK Bioscience Co (XKRX:302440) Total Tax Payable : ₩6,994 Mil (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is SK Bioscience Co Total Tax Payable?

SK Bioscience Co's Total Tax Payable for the quarter that ended in Dec. 2024 was ₩6,994 Mil.

SK Bioscience Co's quarterly Total Tax Payable stayed the same from Jun. 2024 (₩0 Mil) to Sep. 2024 (₩0 Mil) but then increased from Sep. 2024 (₩0 Mil) to Dec. 2024 (₩6,994 Mil).

SK Bioscience Co's annual Total Tax Payable declined from Dec. 2022 (₩20,216 Mil) to Dec. 2023 (₩0 Mil) but then increased from Dec. 2023 (₩0 Mil) to Dec. 2024 (₩6,994 Mil).

SK Bioscience Co Total Tax Payable Historical Data

The historical data trend for SK Bioscience Co's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SK Bioscience Co Total Tax Payable Chart

SK Bioscience Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Tax Payable

Get a 7-Day Free Trial

22,431.29

101,485.88

20,215.89

6,994.32

SK Bioscience Co Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Tax Payable	Get a 7-Day Free Trial															-	-	-	-	6,994.32

SK Bioscience Co Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.

SK Bioscience Co Total Tax Payable Related Terms

Thank you for viewing the detailed overview of SK Bioscience Co's Total Tax Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

SK Bioscience Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SK Bioscience Co Ltd (XKRX:302440) » Definitions » Total Tax Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

310, Pangyo-ro, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13494

Website

https://www.skbioscience.co.kr

SK Bioscience Co Ltd is a South Korean pharmaceutical company. It is engaged in the manufacturing and developing of vaccine. The company has registered SKYCellflu prefilled syringe (PFS), the first cell culture influenza vaccine in Korea, followed by the licensure of SKYCellflu Quadrivalent prefilled syringe and 13-valent Pneumococcal Conjugate Vaccine. Further it has several other vaccines under development and clinical trials including recombinant rotavirus vaccine. In addition, the development of new typhoid conjugate vaccine and innovative pneumococcal vaccine is ongoing in collaboration with external partners.

SK Bioscience Co Headlines

No Headlines